MPLX LP And Enbridge On The List Of Winners And Losers Of Wednesday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today‚Äôs list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are MPLX LP, Cronos Group, and Ambev.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 MPLX LP (MPLX) 34.93 0.06% 2023-09-06 06:32:55
2 Cronos Group (CRON) 2.06 0% 2023-09-06 06:26:44
3 Ambev (ABEV) 2.78 0% 2023-09-06 07:22:25
4 GameStop (GME) 19.10 -0.68% 2023-09-06 07:25:52
5 Inovio Pharmaceuticals (INO) 0.46 -0.87% 2023-09-06 06:23:32
6 Vodafone (VOD) 9.23 -1.39% 2023-09-06 06:25:53
7 Enbridge (ENB) 32.83 -6.97% 2023-09-06 07:25:13

The three biggest losers today are Enbridge, Vodafone, and Inovio Pharmaceuticals.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Enbridge (ENB) 32.83 -6.97% 2023-09-06 07:25:13
2 Vodafone (VOD) 9.23 -1.39% 2023-09-06 06:25:53
3 Inovio Pharmaceuticals (INO) 0.46 -0.87% 2023-09-06 06:23:32
4 GameStop (GME) 19.10 -0.68% 2023-09-06 07:25:52
5 Cronos Group (CRON) 2.06 0% 2023-09-06 06:26:44
6 Ambev (ABEV) 2.78 0% 2023-09-06 07:22:25
7 MPLX LP (MPLX) 34.93 0.06% 2023-09-06 06:32:55

Premarket Winners today

1. MPLX LP (MPLX) – Premarket: 0.06%

MPLX LP owns and operates midstream energy infrastructure and logistics assets primarily in the United States. It operates in two segments, Logistics and Storage, and Gathering and Processing. The company is involved in the gathering, processing, and transportation of natural gas; gathering, transportation, fractionation, exchange, storage, and marketing of natural gas liquids; gathering, storage, transportation, and distribution of crude oil and refined products, as well as other hydrocarbon-based products; and sale of residue gas and condensate. It also engages in the inland marine businesses comprising transportation of light products, heavy oils, crude oil, renewable fuels, chemicals, and feedstocks in the Mid-Continent and Gulf Coast regions, as well as owns and operates boats and barges, including third-party chartered equipment, and a marine repair facility located on the Ohio River; and distribution of fuel, as well as operates refining logistics, terminals, rail facilities, and storage caverns. In addition, the company operates terminal facilities for the receipt, storage, blending, additization, handling, and redelivery of refined petroleum products through the pipeline, rail, marine, and over-the-road modes of transportation. MPLX GP LLC acts as the general partner of MPLX LP. The company was incorporated in 2012 and is headquartered in Findlay, Ohio. MPLX LP operates as a subsidiary of Marathon Petroleum Corporation.

NYSE ended the session with MPLX LP sliding 0.08% to $34.91 on Wednesday, after two consecutive sessions in a row of losses. NYSE slid 0.93% to $15,942.48, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, MPLX LP has a trailing twelve months EPS of $3.95.

PE Ratio

MPLX LP has a trailing twelve months price to earnings ratio of 8.84. Meaning, the purchaser of the share is investing $8.84 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.6%.

Volume

Today’s last reported volume for MPLX LP is 223884 which is 87.58% below its average volume of 1802680.

More news about MPLX LP.

2. Cronos Group (CRON) – Premarket: 0%

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

NASDAQ ended the session with Cronos Group rising 10.16% to $2.06 on Wednesday, following the last session’s upward trend. NASDAQ fell 0.08% to $14,020.95, after two sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Cronos Group has a trailing twelve months EPS of $-0.39.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.1%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 11.9%, now sitting on 86.11M for the twelve trailing months.

Moving Average

Cronos Group’s worth is way above its 50-day moving average of $1.85 and below its 200-day moving average of $2.16.

Volatility

Cronos Group’s last week, last month’s, and last quarter’s current intraday variation average was 2.79%, 0.37%, and 2.91%.

Cronos Group’s highest amplitude of average volatility was 6.85% (last week), 3.20% (last month), and 2.91% (last quarter).

More news about Cronos Group.

3. Ambev (ABEV) – Premarket: 0%

Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands. The company also provides carbonated soft drinks, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi-Cola, Canada Dry, Squirt, Red Rock, Red Bull, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands. It offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.

NYSE ended the session with Ambev falling 3.65% to $2.78 on Wednesday, following the last session’s upward trend. NYSE dropped 0.93% to $15,942.48, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Ambev has a trailing twelve months EPS of $0.19.

PE Ratio

Ambev has a trailing twelve months price to earnings ratio of 14.61. Meaning, the purchaser of the share is investing $14.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.92%.

Volatility

Ambev’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.81%, a negative 0.35%, and a positive 1.23%.

Ambev’s highest amplitude of average volatility was 2.17% (last week), 1.02% (last month), and 1.23% (last quarter).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Dec 19, 2022, the estimated forward annual dividend rate is 0.14 and the estimated forward annual dividend yield is 5.21%.

Sales Growth

Ambev’s sales growth is 5.3% for the current quarter and 7.1% for the next.

Volume

Today’s last reported volume for Ambev is 5683450 which is 56.54% below its average volume of 13077800.

More news about Ambev.

4. GameStop (GME) – Premarket: -0.68%

GameStop Corp., a specialty retailer, provides games and entertainment products through its stores and ecommerce platforms in the United States, Canada, Australia, and Europe. The company sells new and pre-owned gaming platforms; accessories, such as controllers, gaming headsets, and virtual reality products; new and pre-owned gaming software; and in-game digital currency, digital downloadable content, and full-game downloads. It also sells collectibles comprising apparel, toys, trading cards, gadgets, and other retail products for pop culture and technology enthusiasts, as well as engages in the digital asset wallet and NFT marketplace activities. The company operates stores and ecommerce sites under the GameStop, EB Games, and Micromania brands; and pop culture themed stores that sell collectibles, apparel, gadgets, electronics, toys, and other retail products under the Zing Pop Culture brand, as well as offers Game Informer magazine, a print and digital gaming publication. The company was formerly known as GSC Holdings Corp. GameStop Corp. was founded in 1996 and is headquartered in Grapevine, Texas.

NYSE ended the session with GameStop rising 4.68% to $19.23 on Wednesday while NYSE dropped 0.93% to $15,942.48.

Earnings Per Share

As for profitability, GameStop has a trailing twelve months EPS of $-0.71.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.3%, now sitting on 5.79B for the twelve trailing months.

Moving Average

GameStop’s worth is below its 50-day moving average of $21.27 and way below its 200-day moving average of $21.45.

More news about GameStop.

5. Inovio Pharmaceuticals (INO) – Premarket: -0.87%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals rising 1.78% to $0.46 on Wednesday, after two sequential sessions in a row of gains. NASDAQ slid 0.08% to $14,020.95, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -72.13%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Inovio Pharmaceuticals’s EBITDA is -4.48.

Volatility

Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was 0.16%, 0.09%, and 4.29%.

Inovio Pharmaceuticals’s highest amplitude of average volatility was 0.18% (last week), 3.03% (last month), and 4.29% (last quarter).

Sales Growth

Inovio Pharmaceuticals’s sales growth is negative 88.7% for the current quarter and negative 43.5% for the next.

More news about Inovio Pharmaceuticals.

6. Vodafone (VOD) – Premarket: -1.39%

Vodafone Group Public Limited Company provides telecommunication services in Europe and internationally. It offers mobile connectivity services comprising end-to-end services for mobile voice and data, messaging, device management, BYOx, and telecoms management, as well as professional and consulting services; and fixed line connectivity, such as fixed voice and data, broadband, software-defined networks, managed WAN, LAN, ethernet, and satellite; and financial services, as well as business and merchant services. The company also provides consumer Internet of Things (IoT) propositions, as well as security and insurance products; mobile services; logistics, fleet management, and smart metering services; WiFi; digital services comprising mobile application development, multi-access edge computing, worker insights, AI assistant, drone detection, visual inspection, and mixed reality, as well as Vodafone Analytics platform; and traditional IT hosting services, including colocation, managed hosting, security, hosting infrastructure, and flexible computing for government. In addition, it offers integrated business communication services, as well as fixed mobile convergence services; and carrier services, as well as IoT devices comprising managed tablets and integrated terminals. Further, it offers M-Pesa, an African mobile money platform to make payments and provide financial services; Vodafone Business multi-cloud platform; and productivity solutions, as well as operates digital cloud-based television platforms. It serves private and public sector customers in the manufacturing, retail, automotive, banking finance, healthcare, smart cities and public, agriculture, transport and logistics, and energy and utilities management industries. It offers its products and services through digital and physical channels. Vodafone Group Public Limited Company has a strategic partnership with Open Fiber. The company was incorporated in 1984 and is based in Newbury, the United Kingdom.

NASDAQ ended the session with Vodafone dropping 0% to $9.36 on Wednesday while NASDAQ dropped 0.08% to $14,020.95.

Earnings Per Share

As for profitability, Vodafone has a trailing twelve months EPS of $4.6.

PE Ratio

Vodafone has a trailing twelve months price to earnings ratio of 2.03. Meaning, the purchaser of the share is investing $2.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.3%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jun 7, 2023, the estimated forward annual dividend rate is 0.98 and the estimated forward annual dividend yield is 10.8%.

Yearly Top and Bottom Value

Vodafone’s stock is valued at $9.36 at 08:34 EST, way under its 52-week high of $13.68 and above its 52-week low of $8.93.

Moving Average

Vodafone’s value is under its 50-day moving average of $9.36 and way below its 200-day moving average of $10.65.

Volume

Today’s last reported volume for Vodafone is 1483720 which is 72.79% below its average volume of 5454410.

More news about Vodafone.

7. Enbridge (ENB) – Premarket: -6.97%

Enbridge Inc., together with its subsidiaries, operates as an energy infrastructure company. The company operates through five segments: Liquids Pipelines, Gas Transmission and Midstream, Gas Distribution and Storage, Renewable Power Generation, and Energy Services. The Liquids Pipelines segment operates pipelines and related terminals to transport various grades of crude oil and other liquid hydrocarbons in Canada and the United States. The Gas Transmission and Midstream segment invests in natural gas pipelines and gathering and processing facilities in Canada and the United States. The Gas Distribution and Storage segment is involved in the natural gas utility operations serving residential, commercial, and industrial customers in Ontario, as well as natural gas distribution activities in Quebec. The Renewable Power Generation segment operates power generating assets, such as wind, solar, geothermal, waste heat recovery, and transmission assets in North America. The Energy Services segment provides physical commodity marketing and logistical services to refiners, producers, and other customers in Canada and the United States. The company was formerly known as IPL Energy Inc. and changed its name to Enbridge Inc. in October 1998. Enbridge Inc. was founded in 1949 and is headquartered in Calgary, Canada.

NYSE ended the session with Enbridge jumping 0.09% to $35.29 on Wednesday while NYSE dropped 0.93% to $15,942.48.

Earnings Per Share

As for profitability, Enbridge has a trailing twelve months EPS of $1.38.

PE Ratio

Enbridge has a trailing twelve months price to earnings ratio of 25.57. Meaning, the purchaser of the share is investing $25.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.44%.

Sales Growth

Enbridge’s sales growth is 2.4% for the ongoing quarter and 6.4% for the next.

Volatility

Enbridge’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.03%, a negative 0.09%, and a positive 0.83%.

Enbridge’s highest amplitude of average volatility was 0.79% (last week), 0.83% (last month), and 0.83% (last quarter).

More news about Enbridge.

Premarket Losers Today

1. Enbridge (ENB) – Premarket: -6.97%

Enbridge Inc., together with its subsidiaries, operates as an energy infrastructure company. The company operates through five segments: Liquids Pipelines, Gas Transmission and Midstream, Gas Distribution and Storage, Renewable Power Generation, and Energy Services. The Liquids Pipelines segment operates pipelines and related terminals to transport various grades of crude oil and other liquid hydrocarbons in Canada and the United States. The Gas Transmission and Midstream segment invests in natural gas pipelines and gathering and processing facilities in Canada and the United States. The Gas Distribution and Storage segment is involved in the natural gas utility operations serving residential, commercial, and industrial customers in Ontario, as well as natural gas distribution activities in Quebec. The Renewable Power Generation segment operates power generating assets, such as wind, solar, geothermal, waste heat recovery, and transmission assets in North America. The Energy Services segment provides physical commodity marketing and logistical services to refiners, producers, and other customers in Canada and the United States. The company was formerly known as IPL Energy Inc. and changed its name to Enbridge Inc. in October 1998. Enbridge Inc. was founded in 1949 and is headquartered in Calgary, Canada.

NYSE ended the session with Enbridge rising 0.09% to $35.29 on Wednesday, following the last session’s downward trend. NYSE slid 0.93% to $15,942.48, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Enbridge has a trailing twelve months EPS of $1.38.

PE Ratio

Enbridge has a trailing twelve months price to earnings ratio of 25.57. Meaning, the purchaser of the share is investing $25.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.44%.

Yearly Top and Bottom Value

Enbridge’s stock is valued at $35.29 at 08:34 EST, way under its 52-week high of $43.04 and higher than its 52-week low of $33.96.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 10% and positive 17% for the next.

Volatility

Enbridge’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.03%, a negative 0.09%, and a positive 0.83%.

Enbridge’s highest amplitude of average volatility was 0.79% (last week), 0.83% (last month), and 0.83% (last quarter).

Volume

Today’s last reported volume for Enbridge is 625578 which is 84.56% below its average volume of 4054060.

More news about Enbridge.

2. Vodafone (VOD) – Premarket: -1.39%

Vodafone Group Public Limited Company provides telecommunication services in Europe and internationally. It offers mobile connectivity services comprising end-to-end services for mobile voice and data, messaging, device management, BYOx, and telecoms management, as well as professional and consulting services; and fixed line connectivity, such as fixed voice and data, broadband, software-defined networks, managed WAN, LAN, ethernet, and satellite; and financial services, as well as business and merchant services. The company also provides consumer Internet of Things (IoT) propositions, as well as security and insurance products; mobile services; logistics, fleet management, and smart metering services; WiFi; digital services comprising mobile application development, multi-access edge computing, worker insights, AI assistant, drone detection, visual inspection, and mixed reality, as well as Vodafone Analytics platform; and traditional IT hosting services, including colocation, managed hosting, security, hosting infrastructure, and flexible computing for government. In addition, it offers integrated business communication services, as well as fixed mobile convergence services; and carrier services, as well as IoT devices comprising managed tablets and integrated terminals. Further, it offers M-Pesa, an African mobile money platform to make payments and provide financial services; Vodafone Business multi-cloud platform; and productivity solutions, as well as operates digital cloud-based television platforms. It serves private and public sector customers in the manufacturing, retail, automotive, banking finance, healthcare, smart cities and public, agriculture, transport and logistics, and energy and utilities management industries. It offers its products and services through digital and physical channels. Vodafone Group Public Limited Company has a strategic partnership with Open Fiber. The company was incorporated in 1984 and is based in Newbury, the United Kingdom.

NASDAQ ended the session with Vodafone falling 0% to $9.36 on Wednesday, following the last session’s upward trend. NASDAQ fell 0.08% to $14,020.95, after two successive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Vodafone has a trailing twelve months EPS of $4.6.

PE Ratio

Vodafone has a trailing twelve months price to earnings ratio of 2.03. Meaning, the purchaser of the share is investing $2.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.3%.

Volatility

Vodafone’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.27%, a negative 0.04%, and a positive 1.15%.

Vodafone’s highest amplitude of average volatility was 0.27% (last week), 0.67% (last month), and 1.15% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.4%, now sitting on 45.71B for the twelve trailing months.

More news about Vodafone.

3. Inovio Pharmaceuticals (INO) – Premarket: -0.87%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals rising 1.78% to $0.46 on Wednesday while NASDAQ slid 0.08% to $14,020.95.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -72.13%.

Volume

Today’s last reported volume for Inovio Pharmaceuticals is 394590 which is 94.47% below its average volume of 7142020.

Sales Growth

Inovio Pharmaceuticals’s sales growth is negative 88.7% for the present quarter and negative 43.5% for the next.

Volatility

Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was 0.16%, 0.09%, and 4.29%.

Inovio Pharmaceuticals’s highest amplitude of average volatility was 0.18% (last week), 3.03% (last month), and 4.29% (last quarter).

More news about Inovio Pharmaceuticals.

4. GameStop (GME) – Premarket: -0.68%

GameStop Corp., a specialty retailer, provides games and entertainment products through its stores and ecommerce platforms in the United States, Canada, Australia, and Europe. The company sells new and pre-owned gaming platforms; accessories, such as controllers, gaming headsets, and virtual reality products; new and pre-owned gaming software; and in-game digital currency, digital downloadable content, and full-game downloads. It also sells collectibles comprising apparel, toys, trading cards, gadgets, and other retail products for pop culture and technology enthusiasts, as well as engages in the digital asset wallet and NFT marketplace activities. The company operates stores and ecommerce sites under the GameStop, EB Games, and Micromania brands; and pop culture themed stores that sell collectibles, apparel, gadgets, electronics, toys, and other retail products under the Zing Pop Culture brand, as well as offers Game Informer magazine, a print and digital gaming publication. The company was formerly known as GSC Holdings Corp. GameStop Corp. was founded in 1996 and is headquartered in Grapevine, Texas.

NYSE ended the session with GameStop rising 4.68% to $19.23 on Wednesday while NYSE fell 0.93% to $15,942.48.

Earnings Per Share

As for profitability, GameStop has a trailing twelve months EPS of $-0.71.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GameStop’s stock is considered to be overbought (>=80).

More news about GameStop.

5. Cronos Group (CRON) – Premarket: 0%

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

NASDAQ ended the session with Cronos Group rising 10.16% to $2.06 on Wednesday while NASDAQ slid 0.08% to $14,020.95.

Earnings Per Share

As for profitability, Cronos Group has a trailing twelve months EPS of $-0.39.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.1%.

Moving Average

Cronos Group’s worth is way above its 50-day moving average of $1.85 and below its 200-day moving average of $2.16.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Cronos Group’s stock is considered to be overbought (>=80).

More news about Cronos Group.

6. Ambev (ABEV) – Premarket: 0%

Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands. The company also provides carbonated soft drinks, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi-Cola, Canada Dry, Squirt, Red Rock, Red Bull, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands. It offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.

NYSE ended the session with Ambev dropping 3.65% to $2.78 on Wednesday, following the last session’s upward trend. NYSE fell 0.93% to $15,942.48, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Ambev has a trailing twelve months EPS of $0.19.

PE Ratio

Ambev has a trailing twelve months price to earnings ratio of 14.61. Meaning, the purchaser of the share is investing $14.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.92%.

More news about Ambev.

7. MPLX LP (MPLX) – Premarket: 0.06%

MPLX LP owns and operates midstream energy infrastructure and logistics assets primarily in the United States. It operates in two segments, Logistics and Storage, and Gathering and Processing. The company is involved in the gathering, processing, and transportation of natural gas; gathering, transportation, fractionation, exchange, storage, and marketing of natural gas liquids; gathering, storage, transportation, and distribution of crude oil and refined products, as well as other hydrocarbon-based products; and sale of residue gas and condensate. It also engages in the inland marine businesses comprising transportation of light products, heavy oils, crude oil, renewable fuels, chemicals, and feedstocks in the Mid-Continent and Gulf Coast regions, as well as owns and operates boats and barges, including third-party chartered equipment, and a marine repair facility located on the Ohio River; and distribution of fuel, as well as operates refining logistics, terminals, rail facilities, and storage caverns. In addition, the company operates terminal facilities for the receipt, storage, blending, additization, handling, and redelivery of refined petroleum products through the pipeline, rail, marine, and over-the-road modes of transportation. MPLX GP LLC acts as the general partner of MPLX LP. The company was incorporated in 2012 and is headquartered in Findlay, Ohio. MPLX LP operates as a subsidiary of Marathon Petroleum Corporation.

NYSE ended the session with MPLX LP falling 0.08% to $34.91 on Wednesday while NYSE slid 0.93% to $15,942.48.

Earnings Per Share

As for profitability, MPLX LP has a trailing twelve months EPS of $3.95.

PE Ratio

MPLX LP has a trailing twelve months price to earnings ratio of 8.84. Meaning, the purchaser of the share is investing $8.84 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.6%.

More news about MPLX LP.

Stay up to date with our premarket winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *